Galectin Therapeutics Stock Price (NASDAQ:GALT)

Add to My Stocks
$5.62 $0.2 (3.44%) GALT stock closing price Jul 20, 2018 (Closing)
Prev Close* : $5.82
Market Cap:
$218.66M
Day Low: $5.57
52 Week Low: $1.28
Open: $5.8
Volume: -
Day High: $5.9
52 Week High: $9.49
Dividend:
0.00

Latest Stock Market News

Latest Articles

Galectin Therapeutics News - From Partners

Galectin Therapeutics Inc. Announces New CEO   by Globe Newswire on Jun 12, 2018

GALT Stockcharts

View GALT PE ratio, PS ratio stocks charts and compare with peers.
GALT Chart
Note: Compare Galectin Therapeutics stock price history with the index and industry peers.

Galectin Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Galectin Therapeutics Returns

ROE
(return on equity)

Galectin Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

GALT Industry Peers

Company Price Change (%)
Neptune Tech. & Bio. (NEPT)2.810.11 (3.77%)
Jounce Theraptc (JNCE)7.570.21 (2.7%)
Enanta Pharma (ENTA)122.340.79 (0.64%)
Galmed Pharma (GLMD)150.02 (0.13%)
Medicinova (MNOV)8.530.4 (4.48%)
Gilead Sciences (GILD)77.370.32 (0.42%)
Melinta Therapt (MLNT)5.950.1 (1.65%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
PTC Therapeutics (PTCT)39.983.43 (9.38%)
Adamis Pharma (ADMP)3.80.15 (4.11%)
Rigel Pharma (RIGL)3.10.12 (4.03%)
La Jolla Pharma (LJPC)32.271.21 (3.9%)
CASI Pharma (CASI)7.350.27 (3.81%)
CTI BioPharma (CTIC)2.350.08 (3.52%)
ArQule (ARQL)5.380.17 (3.26%)
Top gainers from Medical-Drugs industry
* As of Jul 21, 2018
CompanyPriceChange (%)
Neptune Tech. & Bio. (NEPT)2.810.11 (3.77%)
Redhill Biopharma (RDHL)9.960.39 (3.77%)
Achaogen (AKAO)7.140.27 (3.64%)
Infinity Pharma (INFI)1.910.07 (3.54%)
Lannett Co (LCI)12.350.45 (3.52%)
Galectin Therapeutics (GALT)5.620.2 (3.44%)
Tesaro Inc (TSRO)39.240.99 (2.46%)
Top losers from Medical-Drugs industry
* As of Jul 21, 2018

Galectin Therapeutics Inc Stock News - Partner Headlines

Galectin Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-16.23M-21.43M-20.02M-15.78M-12.08M
Total Operating Expense16.24M21.47M20.07M15.42M12.09M
View Galectin Therapeutics income statement
balance sheet20172016201520142013
Total Assets4.16M15.79M26.4M29.67M10.71M
Total Liabilities2.96M3.78M1.36M1.7M2.48M
Shareholders Equity1.19M12.01M25.04M27.97M8.22M
View Galectin Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.8M2.54M-0.36M-1.11M-
Net Cash from (used by) Operating Activities-15.89M-16.4M-16.98M-12.42M-7.48M
Increase (Decrease) in Prop Plant And Equipment-----
View Galectin Therapeutics cash flow statement

Galectin Therapeutics Stock Message Board

Galectin Therapeutics stock price ended the last trading day at $5.62. The total market value as denoted by $218.66M for Galectin Therapeutics, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Galectin Therapeutics stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy GALT stock than sell it, then Galectin Therapeutics stock price goes up. Conversely, if more investors wanted to sell GALT stock than buy it, there would be greater supply than demand, and the stock price would fall. 516,877 shares were traded with a closing stock price of $5.62 as of Jul 20, 2018, as can be seen from Galectin Therapeutics stock quote. One can view Galectin Therapeutics stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Galectin Therapeutics does not pay dividends. Galectin Therapeutics stock price history, gives the entire historical data for GALT stock.